Jynarque
The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.
Jynarque helps slow worsening of kidney function in patients with ADPKD, a genetic disease in which cysts form in the kidney. Do not drink grapefruit juice during treatment.
Jynarque Overview
Jynarque is a prescription medication used to prevent worsening of kidney function in patients with autosomal dominant polycystic kidney disease (ADPKD) who are at risk for rapid decline. Jynarque belongs to a group of drugs called vasopressin 2 receptor antagonists, which work to block the action of vasopressin and slow the growth of cysts in the kidney.
This medication comes in tablet form and is taken 2 times per day: once upon waking and once 8 hours later.
Common side effects of Jynarque include increased urination, thirst, and dry mouth. Jynarque can also cause drowsiness. Do not drive or operate heavy machinery until you know how Jynarque affects you.
How was your experience with ?
Jynarque Drug Class
Jynarque is part of the drug class:
Jynarque FDA Warning
WARNING: RISK OF SERIOUS LIVER INJURY
Jynarque can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported.
Measure ALT, AST and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then monthly for the first 18 months and every 3 months thereafter. Prompt action in response to laboratory abnormalities, signs, or symptoms indicative of hepatic injury can mitigate, but not eliminate, the risk of serious hepatotoxicity.
Because of the risks of serious liver injury, Jynarque is available only through a restricted distribution program under a Risk Evaluation and Mitigation Strategy (REMS) called the Jynarque REMS Program.